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Bacterial infections of the pulmonary system are increasing. With almost half of today's infections being
caused by strains of bacteria that are resistant to existing conventional antibiotics, there is an urgent need
for the development of novel therapeutic platforms. Silver nanoparticles (AgNPs) have been receiving
increasing attention due to their unique antibacterial properties, and whilst the biological efficacy of silver
is well known, the mechanisms by which AgNPs degrade within cells and how these processes correlate to
their bioreactivity are poorly understood. This review summarises the current knowledge on the
bactericidal pathways of AgNPs and discusses the challenges to be faced before we are able to develop
efficient and safe antibacterial agents for the treatment of bacterial infections in the lung.al health, public safety and
normous benefit via highly
. Despite numerous reports,
rties of AgNMs are linked to
ture is discussed in the con-Introduction
Recent advances in the research and development of
engineered nanomaterials have enabled a wide range of novel
applications for commercial and industrial uses. One field
that nanoparticles are expected to revolutionise is medicine,
through the design of complex structures that can be targeted
to specific tissues, have mechanisms for controlled release
and evade rapid clearance.1,2 The lung is a particularly attrac-
tive target for nanomedicine, to treat pulmonary as well as
systemic disease. Its large surface area and circumvention of
first pass metabolism allow for high drug absorption. More-
over, inhalable drugs are non-invasive and can be self-admin-
istered, while their nano-size allows them to penetrate in the
deep lung and reach the alveolar region more efficiently than
larger particles. There are currently several types ofnanoparticles being developed for respiratory applications,
which aim to overcome the limitations of conventional drugs
and be used for the treatment of numerous lung diseases,
such as asthma, bacterial infections, emphysema, cystic fibro-
sis, cancer and others (Table 1).3 A major part of research on
drug delivery nanoformulations has previously been devoted
on “soft” nanoparticles, such as solid lipid nanoparticles,
organic polymers and liposomes.3 Recently there has also been
a move toward the use of “hard” inorganic nanoparticles, like
carbon nanotubes or noble metal nanoparticles.1 In both
cases, nanoparticles have often been used as vehicles for the
administration of active pharmaceutical ingredients in the
lungs. Silver has been used as a disinfectant since antiquity;4
therefore silver nanoparticles are receiving increasing attention
for their inherent antibacterial properties and have already
been incorporated in several consumer products (e.g. wound
dressings, antibacterial textiles, cosmetic and hygiene prod-
ucts, antibacterial sprays, nasal drops). Consequently, AgNPs
represent an exciting opportunity for the development of plat-
forms for the treatment of pulmonary bacterial infections.oyal Society of Chemistry 2015
Table 1 Examples of nanoparticle systems for pulmonary applications
Type of
nanoparticle Application Ref.
Solid lipid
nanoparticles
Asthma 96
Lung cancer 97
Cystic fibrosis 98
Tuberculosis 99
Insulin delivery 100
Pulmonary hypertension 101
Polymeric
nanoparticles
Pulmonary fibrosis 102
Lung cancer 103
Anti-oxidant delivery 104
Lung infections 105
Anticoagulant delivery 106
Pulmonary hypertension 107
Gene delivery 108
Liposomes Asthma 109
Anti-oxidant delivery 110
Bacterial infections 111
Pulmonary arterial hypertension 112
Surfactant therapy 113
Polymeric
liposomes
Gene delivery 114
Protein and peptide delivery 115
Lipid
nanoparticles
Asthma 116
Lung infections 117
Dried
nanoparticles
Anti-inflammatory 118
Lung cancer 119
Pulmonary infections 120
Self-assembly
nanoparticles
Antibody delivery 121
Carbon nanotubes Cancer 122
Silver
nanoparticles
Anti-proliferative effects in cancer
cells
123,
124
Gold nanoparticles Lung cancer diagnosis 125
Anti-cancer drug delivery 126
Simultaneous magnetic resonance
imaging (MRI) and therapy
127
Photodynamic therapy 128
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View Article OnlineAmong lung diseases, invasive microbial infections affect-
ing the lungs are increasing in incidence and diversity.5
Although the lung is constantly exposed to potential infec-
tious agents, the extraordinary natural defence mechanisms
of the respiratory tract may, in most cases, prevent serious
infections. The most common causes of bacterial lung infec-
tions include Streptococcus pneumoniae, Haemophilus species,
Staphylococcus aureus and Mycobacterium tuberculosis.6 After
infection, bacteria bound to the surface of macrophages are
rapidly internalised into phagosomes, which engage with
endosomal trafficking processes and gradually acquire the
characteristics of terminal phagolysosomes, an event con-
comitant with the death of the microbe. Pulmonary macro-
phages have a key role in the defence against respiratory
infections produced by viruses, bacteria, mycobacteria and
fungi. Together with dendritic cells, they are active producers
of cytokines and leukotrienes, and have important pro- and
anti-inflammatory roles in the alveoli and airway submucosa,
respectively.7 However, some pathogens, such as Legionella
spp. and Mycobacteria spp., can alter lysosome trafficking7
and phagolysosome fusion8 or even block host macrophage
apoptosis by a TNF receptor-dependent mechanism9,10 in
order to survive inside cells.This journal is © The Royal Society of Chemistry 2015In the last two decades, the rate at which bacteria are
becoming resistant to current antibiotic treatments has
increased substantially, leading to an urgent need for the
development of new antibiotics (World Health Organisation,
2014). Silver nanoparticles are considered as potential thera-
peutic agents which could have a significant impact on respi-
ratory research and medicine, by offering a multifunctional
platform that could simultaneously diagnose and treat bacte-
rial infections.11–13 The antibacterial properties of AgNPs
have been shown to depend on several physicochemical prop-
erties of the particles, including their size, shape, chemistry
and surface coating.14–17 Currently, the mechanisms by which
AgNPs are able to reduce the activity of bacteria are believed
to arise due to a synergistic effect, including both direct
particle-specific biological effects and also the release of Ag+
ions.18,19 However, several discrepancies in the published lit-
erature need to be addressed in order to draw accurate links
between the physicochemical properties of the particles and
the observed biological effects. Moreover, the same proper-
ties that make AgNPs excellent antimicrobial agents may
also exert adverse effects on pulmonary structure and func-
tion. In fact, Ag+ ions released from AgNP surfaces have
been shown to damage proteins by desulphurisation, gener-
ate reactive oxygen species (ROS)20 or interfere with NO
redox equilibria in airway smooth muscle cells in the lung.21
This oxidative potential may increase the permeability of the
lung epithelium to AgNPs, resulting in DNA damage, lipid
membrane damage, chromosomal aberrations and cell-cycle
arrest.22,23
The effects of AgNPs on bacteria are commonly evaluated
by various in vitro viability measurements, such as minimum
inhibitory concentration (MIC), fractional inhibitory concen-
tration (FIC), zone of inhibition test, and the LIVE/DEAD bac-
terial assays. These assays can provide valuable information
about the antibacterial action and potential cellular toxicity
of AgNPs. However, more detailed mechanistic investigations
of the cellular interactions with AgNPs are necessary in order
to provide insights about how to optimise the design of
AgNPs for the treatment of bacterial infections. Several
reports have illustrated that biophysical interactions may
occur between AgNPs and bacteria, such as biosorption,
AgNP breakdown or aggregation and cellular uptake.24,25
AgNPs can increase the permeability of bacterial cell mem-
branes, penetrate into the cytoplasm and disturb cellular
functions.26
The application of three-dimensional (3D) analytical
electron microscopy in this area could be invaluable,
because it can provide high spatial resolution information
of both the morphology and chemistry of AgNPs. Since the
physicochemical properties of AgNPs may change in the cel-
lular environment, sufficient characterization should take
place not only for as-synthesized particles but also at the
point of exposure, in order to understand what agent of Ag
actually interacts with the cells. Moreover, spatially resolved
maps of the anatomical distribution and physico-chemistry
of AgNPs at the sub-cellular level and observation ofEnviron. Sci.: Nano, 2015, 2, 312–326 | 313
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View Article Onlinechanges in the cellular ultrastructure could help deciphering
the antibacterial mechanisms exerted by nano-Ag. Therefore,
nanoscale imaging methods have the potential to provide
vital information about these systems and, when used in
conjunction with complementary quantitative studies or
other techniques such as low resolution optical imaging,
could provide a holistic understanding of the system
interactions.
In this review, the current literature on the antibacterial
mechanisms of AgNPs against Gram-positive and Gram-
negative bacteria is summarized. The results of studies on
cellular interactions of AgNPs are correlated to the thermody-
namics driving the dissolution of AgNPs in complex314 | Environ. Sci.: Nano, 2015, 2, 312–326
Fig. 1 Electron microscopy images showing morphological alterations in
arrows) and autophagosomes (double arrows) in Pseudomonas aeruginosa
Company Of Biologists. Reproduced with permission of Company of Biolog
nuclei (N) and Mycobacterium tuberculosis bacilli (arrowheads) in infected h
1). Reprinted with permission from ref. 32. Copyright 2012 John Wiley & S
infected with a virulent M.tb strain for 24 h (MOI = 10 : 1). Electron dense
infected cells, compared to uninfected THP-1 cells (D). Reprinted with p
Electron tomography images showing inter-mitochondrial fusion and breac
34. Copyright 2013 Nature Publishing Group. (F) Peripheral nuclear conde
marrow derived macrophages (BMDM) infected with M.tb (MOI = 25 : 1), aft
brane (F2). Reprinted with permission from ref. 33. Copyright 2011 Lee et a
cytoskeleton and intracellular organelles in M.tb-infected macrophages (G
ref. 33. Copyright 2011 Lee et al.physiological environments. Furthermore, we discuss the
mechanistic information that a range of microscopy tech-
niques (including transmission and scanning electron
microscopy, 3D confocal microscopy and dark field micros-
copy) can provide about the key biological processes involved
in bacterial infection of alveolar macrophages, as well as the
cellular uptake of AgNPs and the changes to their physico-
chemical properties occurring within bacteria. Improving our
understanding on the mode of biological action of AgNPs
and the physicochemical properties by which this is driven,
will enable us to design and implement efficient and safe
AgNP antibacterial therapeutics for the treatment of lung
infections.This journal is © The Royal Society of Chemistry 2015
bacteria infected macrophages. (A) Formation of autolysosomes (single
-infected MS-H cells after 1 h (MOI = 10 : 1). Journal of Cell Science by
ists Ltd.29 (B) Distribution of beads (b), lysosomes (Ly), lipid droplets (L),
uman monocyte derived macrophages (HMDM) after 5 days (MOI = 5 :
ons Ltd. (C) Ultrastructural changes in the mitochondria of THP-1 cells
and elongated mitochondria, with prominent cristae were observed in
ermission from ref. 34. Copyright 2013 Nature Publishing Group. (E)
hes in the mitochondrial cell wall. Reprinted with permission from ref.
nsation and partial nuclear protrusion from condensed areas in bone
er 3 h (F1); cells at the late phase of death with damaged plasma mem-
l. (G) Extensive loss of the plasma membrane, exposing the underlying
2) compared to uninfected cells (G1). Reprinted with permission from
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View Article OnlinePhagocytic mechanisms and
morphological alterations in bacteria-
infected macrophages
Since infection is a localized disease, the first step in the
design of actively targeted nano-therapeutics would be to
understand where bacilli reside in infected lungs. The use of
microscopy techniques can provide crucial information about
the topography and the biological processes taking place in
infected lungs. Bacterial phagocytosis by immune cells is the
crucial step in the host defence against microbial invaders.27
The phagosome is a central mediator of both the homeostatic
and microbial functions of macrophages. This phagocytic
vesicle is programmed to degrade internalized material with
high efficiency, through rapid acidification and fusion with
lysosomes, which are rich in proteolytic and lipolytic
enzymes. However, bacilli have developed mechanisms to
escape from phagosomes and enter into autophagosomes for
survival and replication.28 For instance, Yuan et al. demon-
strated that autophagosomes play a regulatory role in the
clearance of Pseudomonas aeruginosa, a bacterium that fre-
quently infects immunodeficient individuals.29 In their work,
the accumulation of typical autophagosomes with double
membranes in infected alveolar macrophages (MS-H) was
identified using transmission electron microscopy (TEM)
(Fig. 1A). Together with TEM imaging, the results of bio-
analytical assays led to the conclusion that P. aeruginosa-
induced autophagy represented a protective host mecha-
nism.29 Recently, the kinetics and mechanical pathways by
which macrophages may interact with, and internalize bacte-
ria, was investigated in depth by Moller et al. using a combi-
nation of microscopy techniques, including scanning
electron microscopy (SEM), differential interference contrast
(DIC) microscopy with interference reflection (IRM) and 3D
confocal microscopy (CM).30 Their findings revealed a
multistep process in which macrophages used filopodia as
phagocytic tentacles to sense and form long-lived interactions
with surface-adhering bacteria (Escherichia coli). In the same
work, fluorescence microscopy showed that Legionella
pneumophila could enter macrophages through a cholesterol-
sensitive pathway, thus avoiding immediate digestion inside
lysosomes by interacting with the autophagy pathway of the
host cells.30
Mycobacterium tuberculosis (M.tb) is the causative agent of
tuberculosis, one of the most devastating infections in the
lung.31 It is well-known that M.tb bacilli may spread infection
by arresting phagosome maturation.31 Infected macrophages
present an increase in the retention of host lipids, which pro-
vides a potential source of nutrients that could be accessed
by bacteria. Confocal microscopy and TEM imaging revealed
the presence of a great number of lipid droplets throughout
the cytoplasm of infected macrophages (Fig. 1B).32 Apart
from inhibiting phagosome maturation as a survival strategy,
M.tb may interfere in processes linked to cell death, such as
apoptosis. Apoptosis is considered as a mechanism wherebyThis journal is © The Royal Society of Chemistry 2015the host cell can contain the infection and eliminate it before
it can spread further throughout the body.33 As shown in
Fig. 1C–E, cells infected with virulent (H37Rv) M.tb strains
present morphological perturbations in the ultrastructure of
mitochondria, such as increased electron density, clear defi-
nition of the cristae and inter-mitochondrial fusion. These
findings suggest an augmentation in the functional activity
of mitochondria, which could be linked to an inhibition of
the apoptotic response.34 Lee et al. investigated the character-
istics and determinants of macrophage cell death caused by
M.tb, using TEM and SEM (Fig. 1F and G).33 Their study pro-
vided evidence that cell death caused by virulent M.tb was
distinct from classical apoptosis. The authors suggested a
mechanism based on the permeabilization of lysosomal
membranes, followed by the destruction of lipid bilayers and
a concomitant degradation of several phospholipid species.33
In conclusion, the use of confocal and electron micros-
copy techniques can provide important information about
key biological signals involved in bacterial infection. Cellular
mechanisms taking place in infected host cells, such as
autophagy or inhibition of phagosome maturation, can be
observed using high resolution imaging. Together with data
obtained from cytotoxicity assays (e.g. mitochondrial activity
measurements), imaging revealing the ultrastructural mor-
phology of cellular organelles, can provide a broader under-
standing about the pathways of cell death. Moreover, the use
of techniques such as immunolabelling, could help identify
molecular ligands involved in the cellular uptake of bacteria.
This information could have a pivotal role in the identifica-
tion of the appropriate targets for the development of anti-
bacterial drugs based on AgNPs. Finally, in future studies,
analytical TEM techniques will be indispensable in the study
of the intracellular localization, and the morphological and
chemical stability of AgNPs applied to bacteria-infected cells.
The thermodynamics of dissolution of
AgNPs
In order to understand and predict how AgNPs behave in bio-
logical environments, it is also essential to understand the
thermodynamics driving the dissolution of this material and
how this is related to the physicochemical properties of the
particles and environmental conditions. Several factors such
as ionic strength and composition of the dispersion
medium,35–38 pH,39,40 dissolved organic matter,41 relative
humidity,42 dissolved oxygen concentration43 and tempera-
ture44 have been shown to alter the properties and dissolu-
tion rates of AgNPs and are consequently expected to affect
their bioreactivity. Size, charge, and surface modifications of
metallic AgNPs have been shown to affect their
cytotoxicity.43,45–47
Under environmental and physiological conditions, metal-
lic silver is not thermodynamically stable but has been shown
to oxidize and release Ag+ ions, which are often considered
as the main active species in the biological action of Ag.48
Liu and Hurt have shown that the dissolution of AgNPs is aEnviron. Sci.: Nano, 2015, 2, 312–326 | 315
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View Article Onlinecooperative oxidation that involves both protons (H+) and
dissolved oxygen (O2).
39 They suggested that in simple aque-
ous solutions containing no other oxidants or reductants, the
global reaction stoichiometry is:
(1)
Recently, Zhang et al. developed a kinetic model to
describe Ag+ release, based on the hard sphere theory.49 They
proposed that the oxidation reaction can be expressed by
first-order reaction kinetics and therefore, the Ag+ release rate
can be described by the Arrhenius equation:
(2)
(3)
(4)
where is the Ag+ release rate (mol L−1 h−1), k is the
reaction rate constant (mol h−1), [AgNP], [O2] and [H
+] are the
molar concentrations (mol L−1) of AgNPs, dissolved oxygen
and protons respectively, Eα is the activation energy (J), T is
the temperature (298 K) and A is the frequency factor. Replac-
ing the molar concentration of AgNPs ([AgNP]) by the mass-
based concentration ([Ag]):
(5)
where ρ is the density of Ag (~10.5 g cm−3), r is the AgNP
radius (nm) and NA is the Avogadro constant (~6.023 × 10
23
mol−1), yields:
(6)
Eqn (6) reveals that Ag+ release rates are inversely propor-
tional to the primary particle size, but also depend on the
concentration of AgNPs as well as environmental factors,
such as temperature, dissolved oxygen and pH. Therefore, it
is not surprising that particle size may dictate the toxicity of
AgNPs, as reported by several studies, where a more pro-
nounced bioreactivity of AgNPs was observed for particle size
lower than 10 nm.15,50316 | Environ. Sci.: Nano, 2015, 2, 312–326Unravelling the antibacterial
mechanisms of AgNPs
Since AgNPs are known to dissolve and release Ag+ ions
under physiological conditions, there has been much debate
in the literature as to whether the reactivity of AgNPs arises
due to an ionic35,45 or particulate effect,51–54 or both. The fol-
lowing section discusses the mechanisms by which the
release of Ag+ ions can be correlated to their antibacterial
activity and the influence of the AgNP-cell interface on these
processes.Dissolution of AgNPs and effects of Ag+ ion release on cell
membrane permeability
Recent evidence has suggested that AgNPs exert their antimi-
crobial properties by the localised release of Ag+ ions in the
acidic and aerobic environment of E.coli.18 The bacterial
membrane has an acidic pH and oxidising environment,
which (according to eqn (1)) will accelerate AgNP dissolution
and release of Ag+ ions. This release could disrupt the outer
membrane of bacteria, enhancing AgNP and Ag+ ion uptake
leading to a reduction in cell viability. This hypothesis has
recently been supported by different authors, who used a sen-
sor sensitive to Ag+ ion release to show that the toxicity of
AgNP could be explained entirely by accumulation of intracel-
lular Ag+ ions.16,18
Silver salts alone, such as AgNO3, can also kill bacteria
and damage the surrounding tissue.12,19 Therefore, it is
assumed that one of the most important pathways through
which AgNPs exert their antimicrobial properties is based on
the effect of free Ag+ ions.18,19 Xiu et al. demonstrated that
AgNPs themselves did not affect the biological activity of bac-
teria, only the ionic Ag+.45 In their study, the antibacterial
properties of polyethylene glycol (PEG) coated AgNPs of three
different diameters (2.8 ± 0.47 nm, 4.7 ± 0.20 nm and 10.5 ±
0.59 nm) were evaluated under aerobic and anaerobic condi-
tions, that preclude Ag0 oxidation. Under anaerobic condi-
tions, AgNPs did not exert any effects on the viability of E.
coli, whereas prolonged air exposure induced higher toxicity.
This work showed that AgNPs do not show antibacterial
effects in anaerobic conditions that preclude Ag0 oxidation
and Ag+ ion release.45 However, by removing the oxygen from
the system, the redox active surface of AgNPs could lose its
capability for generating reactive oxygen species (ROS), which
has also been linked to their toxicity,55 as discussed in the
following paragraphs. By not taking this factor into account,
this study cannot completely isolate particulate and ionic
effects. The above findings suggest that the antibacterial
activity of AgNPs could be controlled by modulating Ag+
release, possibly through the manipulation of oxygen avail-
ability, coating agents or NP size.
The mechanism by which Ag+ ions permeate the cell wall,
is thought to be due to a strong interaction between ionic
Ag+ and thiol groups of cysteine residues of proteins present
in the bacterial cell wall. This may lead to the disruption ofThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinethese proteins56,57 and the accumulation of Ag+ ions in the
cell wall.58 It has also been proposed that Ag+ ions can desta-
bilize the membranes of bacteria, leading to the formation of
pits in the bacterial cell wall,59,60 increasing its permeability
and facilitating the internalization of AgNPs and Ag+ ions.18
Based on theoretically calculated and experimentally esti-
mated Ag+ ions affinities, other amino acids such as arginine
and histidine should be better ligands for Ag+ ions, but these
interactions have not been widely investigated.12 The interac-
tion of Ag+ ions with enzymes of the respiratory chain reac-
tion, such as NADH dehydrogenase,61 could lead to the
uncoupling of respiration from ATP synthesis. Ag+ ions may
also bind to transport proteins, causing proton leakage and
collapse of the proton motive force.62,63
Ag+ ions released from AgNPs or chemisorbed on its sur-
face could also be responsible for the catalytic generation of
ROS by serving as electron acceptor.64 ROS are natural by-
products of the metabolism of respiring organisms and,
while small levels can be controlled by the antioxidant
defences of the cells, excess ROS production may produce
oxidative stress.65 ROS mainly target lipids, DNA, RNA and
proteins, causing severe consequences, such as membrane
breakdown and impairment of the mitochondrial function or
of the DNA replication machinery. In bacteria, Ag+ ions would
likely induce ROS generation by impairing the respiratory
chain enzymes, through direct interactions with thiol groups
in these enzymes or with superoxide radical scavenging
enzymes, such as superoxide dismutases.62,64,66
Some authors have also suggested ROS generation directly
from the AgNPs. In one study, where the toxic effects of Ag+
ions, AgCl and AgNPs on nitrifying bacteria were investigated,
the authors reported that all forms of Ag were able to induce
intracellular ROS generation.55 The bacterial inhibition of
each form of Ag was correlated with the corresponding con-
centration of intracellular ROS. However, at the same concen-
tration of ROS, AgNPs were more toxic than the other forms
of Ag, indicating that additional mechanisms contributed to
the overall toxicity.55 The formation of the superoxide anion,
but not of hydroxyl radicals, observed for Ag+ ions,64 was also
observed for E. coli treated with AgNPs.67 In contrast to these
findings, other authors claim that ROS production has a neg-
ligible contribution to the antimicrobial properties of AgNPs.
Sintubin et al. showed that only a small amount of ROS were
induced by the presence of AgNPs and an even smaller
amount was produced in the presence of Ag+ ions alone.68
Taken together, these findings could support the hypothe-
sis that the bacterial properties of AgNPs arise mainly due to
Ag+ ion release from their surface. Morones et al. supported
this hypothesis, demonstrating that Ag+ ions were more toxic
than AgNPs to S. aureus bacteria, in relation to bacterial
growth.24 TEM imaging revealed that the ultrastructural
changes observed in AgNP-treated bacteria were similar to
those induced by Ag+ ions: detachment of the cytoplasm
membrane from the cell wall and formation of a low density
region, rich in agglomerated DNA,69 which protects DNA mol-
ecules from damage induced by external stimuli. Similarly,This journal is © The Royal Society of Chemistry 2015low molecular weight proteins can also accumulate around
the nucleus as a response to Ag+ ion attack.70Direct particle–cell wall interaction
Although the principal mode of antibacterial activity of
AgNPs involves the release of Ag+ ions, studies have demon-
strated that the mechanism by which AgNPs interact with
bacteria involves a combination of both chemical and physi-
cal interactions.16 The small size and extremely large surface
area of AgNPs allows them to make strong contact with the
bacterial cell wall.71 Several studies have reported that AgNPs
are able to adhere to the plasma membrane, change its per-
meability and penetrate inside the cytoplasm.19,25,55,63,72
Studies have shown that a synergistic effect is required,
where Ag+ ions are required for the antibacterial effects of
AgNPs, but cell-NP contact increases Ag+ release and
increases the amount of cellular uptake of particle associated
Ag+ ions.16,18 A report by McQuillan et al. supports the
hypothesis that dissolution at the cell membrane is the pri-
mary mechanism of action of silver nanoparticles.19
Several other studies have demonstrated that AgNPs are
more toxic to bacteria than the Ag+ ions released from the
corresponding AgNPs in the extracellular media.15,40,53,73
Taglietti et al. pointed out that two factors need to be consid-
ered, the release of Ag+ ions in the exposure medium,
referred to as a “long-distance mechanism”, but also a “short-
distance mechanism” at the particle–bacterial membrane
interface.74 Some authors suggested that this short-distance
effect arises due to enhanced dissolution of the AgNPs close
to the bacterial cell wall.16 Recent studies have provided new
insight that may link the discrepancies existing on the rela-
tive effect of AgNPs and Ag+ ions on toxicity.16,18 Bondarenko
et al. examined the effect of three types of AgNPs (uncoated,
PVP-coated and protein-coated) against six bacterial strains
(Gram-negative: E. coli, P. fluorescens, P. putida and P.
aeruginosa and Gram-positive: B. subtilis and S. aureus). Their
data demonstrated that direct contact between the bacterial
cell and AgNPs enhanced the toxicity of AgNPs because the
amount of internalized Ag+ ions released from the particle
surface increased, which could be driven by the proton
motive force of the bacterial membrane that decreases the
local pH to as low as 3.18 Similarly, Ivask et al. analysed the
amount of bioavailable Ag inside bacterial cells using bacte-
rial bioreporters and showed that the concentrations of bio-
available Ag were substantially higher than the amount pre-
dicted based on the concentration of (abiotic) dissolved silver
from the same NPs.16 These findings suggest that the parti-
cle–cell interface plays an essential role in the antibacterial
action of AgNPs and therefore support a synergistic effect
between AgNPs and Ag+ ions where the AgNPs can deliver a
localised ionic dose to the cell.18 The low local pH around
bacterial membranes is expected, according to eqn (6), to
lead to higher AgNP dissolution rates. However, in our previ-
ous work, low pH values promoted the aggregation and coars-
ening of 20 nm citrate-capped AgNPs.75 As discussed in theEnviron. Sci.: Nano, 2015, 2, 312–326 | 317
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View Article Onlinesection “Particle size,” this would compromise the ability of
AgNPs to bind on bacterial cell walls.76 Therefore further
investigation is necessary in order to deconvolute the effects
of each parameter on the bioreactivity of AgNPs.
Particle size is considered as one of the main physico-
chemical properties that affect the bactericidal behaviour of
AgNPs, as explained by eqn (6).15 Metal particles with smaller
diameters present a very high surface area compared to larger
particles, potentially increasing their overall reactivity.77
Morones et al., for instance, demonstrated that the binding
strength of particles to bacteria was dependent on the surface
of interaction.24 Four types of Gram-negative bacteria (E. coli,
V. cholera, P. aeruginosa and S. typhus) were exposed to
AgNPs in the range of 1–100 nm and examined by comple-
mentary analytical electron microscopy techniques, including
TEM in combination with elemental mapping analysis and
high angle annular dark field (HAADF) scanning transmis-
sion electron microscopy (STEM). The combination of these
techniques provided spatially resolved maps showing the
morphological changes of bacteria following incubation with
AgNPs, and the anatomical position of AgNPs inside the cell.
Only the smallest particles, with diameters of 1–10 nm, were
found on the surface of the cell wall and inside the bacteria.
The presence of very small (∼1 nm) AgNPs was detected
using HAADF-STEM, a technique in which images are formed
by electrons that have been scattered to high angles, due to
Rutherford scattering. As a result, the intensity of the images
is related to Z2, which provides high contrast between metal-
lic silver and organic material.78 The authors suggested that
the mechanism through which AgNPs were able to penetrate
into E. coli was mediated by changes to the structure of the
cell wall, which led to an increase in its permeability.25 In
another report, however, AgNPs from 20 nm up to 80 nm
were able to penetrate through the inner and outer mem-
brane of P. aeruginosa, suggesting that bacteria may also
internalize larger particles.26 The data produced in both stud-
ies did not provide enough details about the structural dam-
age induced to the cell membrane or possible differences in
the uptake mechanism of AgNPs of different sizes. Moreover,
the aggregation states of AgNPs in the media used in the two
studies were not characterized, which could be another factor
that affects their uptake. The effect of aggregation was dem-
onstrated for E. coli exposed to 20–30 nm citrate-coated
AgNPs, which were compared to citrate- and polycyclic aro-
matic hydrocarbon (PAH)-coated gold nanoparticles (AuNPs).
TEM and field emission scanning electron microscopy (FEG-
SEM) revealed that the binding of Ag or AuNPs to bacteria
was different depending on their aggregation state. PAH-
coated AuNPs were found to be more strongly bound to cell
walls and penetrated more readily inside bacteria than
citrate-capped AgNPs, which tended to aggregate more read-
ily.76 Consequently, further research is needed in order to
understand if the interaction of AgNPs with bacterial mem-
branes or their internalization is size-dependent and what is
the role of aggregation. Determining the optimal particle size
for enhanced interaction between AgNPs and bacteria will318 | Environ. Sci.: Nano, 2015, 2, 312–326enable an increase of their antibacterial activity while keep-
ing the dose as low as possible. The use of 3D imaging tech-
niques (e.g. electron tomography, focused ion beam scanning
electron microscopy) would be beneficial for this purpose, as
they can provide valuable information about the interaction
dynamics of NPs with and within the cells, which can be lim-
ited or lost in the case of 2D imaging.
Effects of the cell wall structure. Although particle size
might play an important role in the penetration of AgNPs
inside bacteria, structural differences in the organization of
bacterial cell wall may also influence this interaction. Gram-
negative bacteria have a thin peptidoglycan layer (∼2–3 nm)
between the cytoplasmic membrane and the outer mem-
brane.79 In contrast, Gram-positive bacteria lack the outer
membrane, but have an outer peptidoglycan layer about 30
nm thick.80 The thicker cell wall of Gram-positive bacteria
acts as a barrier protecting the cell from penetration of
AgNPs or Ag+ ions into the cytoplasm. Therefore, Gram-
positive bacteria are expected to be more resistant to the
action of AgNPs. The bacterial strain may also modulate the
bioavailability of Ag+ ions liberated from AgNPs by altering:
(i) the extracellular dissolution of AgNPs via bacterial exu-
dates (organic acids, peptides, biosurfactants) or (ii) the cel-
lular uptake of Ag+ ions via cell-NP interactions which are
controlled by the structure and charge of the cell wall.19
Effects of surface coatings and charge. The differences
between the cell wall structure of Gram-positive and Gram-
negative bacteria suggest that the surface chemistry of AgNPs
could also affect their antibacterial activity. 43,46 The surface
charge and coating of AgNPs is a significant factor that
could govern the particle–membrane interactions and subse-
quently the antibacterial effects of AgNPs, supporting the
hypothesis that particle–cell contact may indeed play a role
in modulating the reactivity of AgNPs.19 Bondarenko et al.
compared PVP and protein (casein)-coated colloidal AgNPs
and showed that the antibacterial potency of collagen coated
AgNPs was greater than PVP coated AgNPs, which was attrib-
uted to differences between the affinity of each nanoparticle
type to the cell wall.18 Xiu et al. also showed that the survival
rates of E.Coli to AgNPs was higher for PVP-AgNPs compared
to PEG-AgNPs, however the particle diameters were not com-
parable.45 In one study, electron microscopy demonstrated
that the bacterial cell wall of E. coli tended to attract and
accumulate positively charged PAH-coated AuNPs rather than
negatively charged citrate-capped AgNPs.76 The carboxyl
phosphate and amino groups on the cellular membrane of
Gram-positive and Gram-negative bacteria give them a nega-
tive surface charge.79 The bacterial cell wall would conse-
quently form an electrostatic barrier that limits its interac-
tion with negatively charged AgNPs, but enhances it with
positively charged AgNPs.81 This is supported by a recent
study, in which positively charged AgNPs were shown to
tightly interact with bacterial surfaces, thus resulting in
higher concentrations of bioavailable Ag+ ions from these
particles. Moreover, positively charged AgNPs interfered with
the normal function of the bacterial electron transfer chainThis journal is © The Royal Society of Chemistry 2015
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View Article Onlineand were responsible for ROS generation at the cell
membrane.16
Positively charged surface coatings have been shown to
play a key role in accelerating cell wall breakdown and cyto-
plasm release.76 For example, cationic polymer-stabilized
AgNPs bind to the negatively charged bacterial surface via
electrostatic interactions.81 However, the potential of using
these coatings for biomedical applications remains an obsta-
cle due to the high cytotoxicity of the polymers.82,83 One alter-
native to overcome this problem would be the use of peptides
or polysaccharides containing amine groups.84 In one study,
a pronounced destruction of the bacterial cell wall was
observed in P. aeruginosa exposed to chitosan-coated AgNPs
using SEM.84 Bacitracin A (BA) and polymyxin E (PE) are poly-
peptides with cationic macrocyclicamido groups, which are
known as antimicrobial peptides (AMPs). These peptides
were used by Mei et al. in the synthesis of functionalized
AgNPs for the treatment of both Gram-negative (E. coli and P.This journal is © The Royal Society of Chemistry 2015
Fig. 2 (A) High angle annular dark field-scanning transmission electron mic
tion of 17.0 μg mL−1 AgNO3 (equal to a Ag concentration of 10 μg mL
−1) in R
the solution through a 2 kDa filter membrane and washed 3 times by DI-w
spectra collected from the areas marked 1–2 in (A). (C) Inductively coupled
silver concentrations following incubation at 37 °C for 0.5 h of 17.0 μg m
media (n = 3). (D, E) Physicochemical characterization of silver nanowires
extracted from DCCM-1. (D) Representative bright field transmission elect
area electron diffraction (SAED) pattern obtained from the circled area (ap
same area shown in (D), and EDX spectrum (bottom) collected from the ed
89. Copyright 2013 American Chemical Society.aeruginosa) and Gram-positive bacteria (S. aureus and B.
amyloliquefaciens).85 The immobilization of both peptides on
the AgNP surface increased their antibacterial activity up to a
10-fold without symptoms of bacterial resistance. Fluores-
cence microscopy and TEM revealed that BA/PE-AgNPs were
localized on the surface of bacteria and inside the cytoplasm.
The membrane appeared seriously damaged, showing an
undulating appearance and vesicles emanating from the cell
wall, while some specimens were more severely damaged and
showed cytoplasmic release (Fig. 2). The major target sites for
antimicrobial agents are often present at the outermost layers
of the bacterial cell. The cell wall of Gram-positive bacteria is
rich in teichoic acids, whose main function is to provide
rigidity by attracting cations such as Mg2+.86 AMPs are con-
sidered excellent antimicrobial agents87,88 because their
macrocyclicamido groups can participate in metal–ligand p-
bonding, producing a complex with Ca2+ and Mg2+ cations.
Therefore, it has been suggested that BA and PE on the AgNPEnviron. Sci.: Nano, 2015, 2, 312–326 | 319
roscopy (HAADF-STEM) image of precipitates formed after the incuba-
PMI-1640 at 37 °C for 0.5 h. The precipitates were collected by filtering
ater. (B) The corresponding energy-dispersive X-ray spectroscopy (EDX)
plasma optical emission spectroscopy (ICP-OES) analysis of solubilized
L−1 AgNO3 in DI-water, RPMI-1640, DMEM and DCCM-1 cell culture
(AgNWs) incubated for 6 h at 37 °C in small molecule solutes and salts
ron microscopy (BF-TEM) image of the AgNWs. The inset is a selected
erture size ∼550 nm). (E) HAADF-STEM image (top) obtained from the
ge of the AgNW (circled in E, top). Reprinted with permission from ref.
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View Article Onlinesurface can chelate Mg2+ and Ca2+ and extract them from the
original binding sites in teichoic acids, thus damaging the
bacterial cell wall.85 Moreover, the same study showed the
presence of BA/PE-NPs in the bacterial nucleoid. These find-
ings suggested that AgNPs could bind to ribosomes and chro-
mosomes, resulting in an inhibition of ribosomal function
and a suppression of DNA replication, ultimately causing cell
death.24 The important role that organic surface coronas sur-
rounding nanoparticles may play towards controlling nano-
material properties for biological applications has also been
demonstrated by Daima et al.17 AgNPs were modified by the
surface corona of biologically active polyoxometalates
(POMs), which enhanced the damage to bacterial cells due to
a synergistic antibacterial action of AgNPs and POMs. SEM
micrographs revealed significant physical damage to treated
bacterial cells, such as big holes in the bacterial structure or
even complete disintegration. The modified AgNPs were toxic
to both Gram positive and Gram negative bacteria, while
being biocompatible with PC3 epithelial mammalian cells,
suggesting their potential towards specific antimicrobial
targeting.17
Therefore, surface coatings will affect the dissolution
rates, bioavailability and aggregation state of AgNPs in vitro
and in vivo. AgNPs aggregation or dispersion in cell culture
media can be controlled by modifying their surface proper-
ties (i.e. hydrophobic or hydrophilic coatings), altering their
uptake inside cells by changing their contact with the cell320 | Environ. Sci.: Nano, 2015, 2, 312–326
Table 2 Ag+ ion release studies reported in the literature, using various exper
Type of AgNPs Experimental setup
10.5 ± 4.3 nm PVP-AgNPs 10 μg ml−1 of AgNPs incubated
(half-strength NaCl-free lysogen
for 4 h at 30 °C
14 ± 1.6 nm Citrate-AgNPs 25 μg ml−1 of AgNPs incubated
interacting perchlorate (ClO4) b
tions at pH 5 for 336 h
20 nm Citrate-AgNPs 300 μg ml−1 of AgNPs incubate
strength Hoagland media for 2
20 nm Citrate-AgNPs 12.5 μg ml−1 of AgNPs incubate
cell media for 24 h at 37 °C
40 nm Citrate-AgNPs 10 μg ml−1 of AgNPs incubated
media at pH 4.5 for 24 h at 37
PVP-AgNWs 129 ± 74 nm in diameter
and a bimodal length of 2.8 ± 2.4 μm
and 7.0 ± 2.0 μm
10 μg ml−1 of AgNPs incubated
RPMI1640 and DCCM-1cell me
at 37 °C
10 nm Citrate-AgNPs 12.5 μg ml−1 of AgNPs incubate
or bacterial growth media ( pH
37 °C
n.q.: not quantified. ICP-MS: Inductively coupled plasma mass spe
spectroscopy. AAS: Atomic absorption spectroscopy.membrane. In fact, some publications have demonstrated
how polymer stabilizers may play an important role in deter-
mining the toxicity of AgNPs by reducing the exposure of
cells to particles.46 The surface properties of AgNPs may gov-
ern to a large extent their interaction with bacterial cell walls
via electrostatic attraction, by complexation of metal cations
localized on the cell wall, or through the interaction with
sulphur-containing membrane proteins. Regardless of the
exact mechanism involved, it is clear that AgNP and bacterial
cell wall interactions increase the permeability of the cell wall
and consequently lead to its disruption.
In summary, published literature has provided enough
evidence that the release of Ag+ ions from the surface of
AgNPs may be regarded as the main mechanism of anti-
bacterial activity of AgNPs. However, it is becoming increas-
ingly clear that dissolution of AgNPs in the exposure medium
cannot wholly account for the observed antimicrobial effects.
Additional effects at the particle–bacterial membrane inter-
face and inside the cells seem to play a role in the action of
AgNPs. Therefore, a synergistic effect between Ag+ ions and
AgNPs must be considered in order to obtain accurate con-
clusions on the antibacterial pathways. Recent findings illus-
trate the importance of membrane interactions in the antimi-
crobial activity of AgNPs, as they can translocate across, and
become internalized, directly through the cytoplasm or inside
vesicles, where their subsequent dissolution driven by an
oxidising and acidic pH at the plasma membrane could leadThis journal is © The Royal Society of Chemistry 2015
imental conditions and methodologies
Analytical methodology and
analysis technique
Released Ag +
ions Ref.
in test media
y broth (LB))
Ultracentrifugation (1 h at
390 000 g)
4.4% 18
AAS
in non-
uffer solu-
Ultrafiltration through 2
KDa filter membranes (13
000 rpm)
~2% 75
ICP-OES
d in quarter-
4 h and 336 h
Ultrafiltration through 3 kDa
filter membranes (40min at
5000 g)
17% (24 h) 40%
(336 h)
50
ICP-MS
d in BEGM Centrifugation (1 h at 15 000
rpm)
~4.3% 95
ICP-OES
in BEGM cell
°C
Centrifugation (1 h at 15 000
rpm)
~7% 129
AAS
in DMEM,
dia for 168 h
Ultrafiltration through 2
KDa filter membranes (13
000 rpm)
n.q. 89
ICP-OES
d in DI water
7) for 24 h at
UV-vis 3.5% (DI) 7%
(bacterial growth
media)
16
Centrifugation (1 h at 21 000
g) AAS
16.1% (DI) 26%
(bacterial growth
media)
ctrometry. ICP-OES: Inductively coupled plasma optical emission
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View Article Onlineto very high local concentrations of Ag+ ions.16 Further
research is necessary in order to understand the exact physi-
cochemical and cellular mechanisms underlying these inter-
actions and how they can be exploited in the design of thera-
peutic AgNPs.Importance of materials characterization
Given that several physicochemical properties of AgNPs have
been shown to influence their bioreactivity, characterisation
of these properties in biological systems and in cell culture
media at the point of exposure will be paramount in order to
draw accurate conclusions about their biological activity.35,37
Inductively coupled plasma mass spectrometry and optical
emission spectroscopy (ICP-MS and ICP-OES) or atomic
absorption spectroscopy (AAS) techniques are commonly
used to correlate the dissolution rate of AgNPs with their tox-
icity profiles. Table 2 shows that a wide variety of experimen-
tal setups and analytical methodologies are employed in
in vitro studies to quantify the amount of Ag+ ions released
from AgNPs. However, there are some discrepancies in the
data provided by different authors, probably due to the use
of inconsistent methodologies, an improper NP characterisa-
tion or the lack of dose response considerations in in vitro
systems. This might explain, to some extent, why inconsistentThis journal is © The Royal Society of Chemistry 2015
Fig. 3 TEM images of Gram-positive bacteria (S. areus) (A–E) and Gram-ne
AgNPs, showing ultrastructural damage in bacterial cells induced by AgNPsdissolution rates are observed even when the same types of
AgNPs are used. For instance, in the case of 10 nm citrate-
AgNPs, different dissolution percentages were measured by
UV-vis absorption spectroscopy and AAS, which required a
previous centrifugation step.16 Due to the small size of
AgNPs, they could not be effectively separated from solution
by centrifugation and the values obtained by AAS were anom-
alously high.
Furthermore, our group has recently revealed limitations
in using ICP-OES for analysing Ag+ ion release in cell culture
media.89 This study demonstrated that Ag+ ions bind with
complex protein thiol groups or other anions in the medium
such as Cl−, PO4
3−, S2− and SO4
2−, forming insoluble silver
compounds, e.g. silver oxide and silver chloride (Fig. 3A and
B). These compounds would reduce the bioavailability of
released silver ions and could confound the interpretation of
the Ag+ ion release rate via ICP studies. The authors com-
pared the amount of free Ag+ ions that can be measured
when AgNO3 is added in DI water compared to different cul-
ture media (RPMI, DMEM and DCCM), as shown in Fig. 3C.
Although 100% of Ag+ ions were measured by ICP-OES in DI-
water, the recovery of Ag+ was less than 5% in cell media.
Therefore, non-interacting buffers (e.g. perchlorate buffer
solutions) are needed when studying the dissolution rates of
AgNPs in in vitro studies, with an understanding thatEnviron. Sci.: Nano, 2015, 2, 312–326 | 321
gative bacteria (P. aeruginosa) (F), before (A) and after (B–F) exposure to
. Reprinted with permission from ref. 85. Copyright 2013 Elsevier Ltd.
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View Article Onlinesignificant sequestering of free Ag+ ion will occur in the
in vivo environment. The same study also investigated how
different sources of sulphur in the cellular environment can
lead to transformations of the surface chemistry of AgNWs,
using a set of spatially resolved analytical TEM techniques.
The formation of silver sulphide (Ag2S) crystals on the surface
of AgNWs within 1 h of incubation in DCCM-1 was identified
by high resolution TEM (Fig. 3D and E). In contrast, incuba-
tion of AgNWs in RPMI-1640 or DMEM did not lead to
sulfidation. These findings highlight the need to consider the
effects of cell culture media in the analysis of toxicity assays,
as well as the potential of high resolution analytical TEM for
the detection of insoluble silver species, in contrast to ICP-
OES.89
Determining the fundamental physicochemical properties
of AgNPs (e.g. size, coating and surface properties) in biologi-
cal systems will be vital to understand their bioreactivity and
antibacterial activity. When performing biological assays, the
oxidation kinetics of AgNPs must be studied under the same
biological conditions employed in the assay. To achieve this,
standardized protocols need to be developed, that combine
different techniques such as ICP-MS, UV-vis and high resolu-
tion imaging. There is also an urgent need to develop
methods for the quantification of oxidation rates of AgNPs
inside cells. In most of the published results, it is difficult to
distinguish between the effects induced by AgNPs and/or Ag+
ions, because it is unclear whether NP dissolution occurs in
the extracellular medium before uptake or intracellularly fol-
lowing ingestion. Recently, our group used ion-sensitive fluo-
rescent dyes combined with confocal microscopy to visualize
the amount of ionic Zn2+ released from ZnO NWs inside
human macrophages.90 On the other hand, the development
of a sensitive and selective colorimetric Ag+ detection method
is still under research. Application of these methods could
provide fundamental insight into the mechanisms by which
AgNPs exert their biological effects by deconvoluting the
effects of Ag+ ions and particles.
Conclusions and perspectives
The information presented in this review provides strong evi-
dence to conclude that AgNPs present an exciting opportunity
as antibacterial agents in biomedical applications. Further
research is required to improve our understanding on the
stability of AgNPs and the kinetics of Ag+ ion release in bio-
logical environments. AgNPs are highly dynamic systems,
whose properties can undergo dramatic changes when incu-
bated in biological media, leading for example to aggrega-
tion, the formation of biomolecule coronas or the precipita-
tion of insoluble Ag species. Consequently, characterization
of as-synthesized AgNPs alone is not enough to predict their
biological activity. Appropriate characterization should also
take place in the cell culture media and under the same con-
ditions (e.g. temperature, time) as used in in vitro studies.
Experimental techniques which have been commonly used in
the past for AgNP characterization, such as atomic322 | Environ. Sci.: Nano, 2015, 2, 312–326absorption spectroscopy or dynamic light scattering, have
been proven to possess limitations in detecting transforma-
tions in the physicochemistry of AgNPs in different biological
environments; therefore several complementary techniques
need to be used. Moreover, characterization of AgNPs at the
particle–cell interface to investigate possible transformations
of the particles at the cellular environment can provide valu-
able information about the interactions of AgNPs with cellu-
lar components.
Additionally, results on the mechanism of antibacterial
action of AgNPs remain inconclusive, with further studies
necessary to investigate the synergistic effect between AgNPs
and Ag+ ions, in order to provide a holistic understanding of
the system interactions and elucidate how the physico-
chemical properties of AgNPs affect bacterial responses. Simi-
lar discrepancies also exist in cytotoxicity studies evaluating
the biological effects of AgNPs in host cells. Therefore, the
focus should be placed on bridging the gap between toxico-
logical studies and analytical techniques. While traditional
cytotoxicity assays are extremely useful to evaluate the biolog-
ical activity of AgNPs, new approaches based on the correla-
tive application of high spatial and energy resolution analyti-
cal microscopy techniques may offer an improved
understanding of the mechanisms by which AgNPs interact
with cells, and can guide the selection of particular toxicolog-
ical assays to test. For example, cytoplasmic localization of
AgNPs could be correlated with plasma membrane perme-
ability and reactive oxygen species (ROS) generation; mito-
chondrial AgNP localization could be related to measure-
ments of mitochondrial membrane potential; or nuclear
localization of AgNPs could be correlated with genotoxicity
assays.16 Imaging and analysis also allows us to determine
whether the toxicological findings relate directly to the loca-
tion of AgNPs in the cell, or whether they are more general.
The development of new methods for the quantification of
Ag+ ions released intracellularly will also prove invaluable in
discriminating between the effects of AgNPs and Ag+ ions.
Understanding which properties of AgNPs drive their bio-
reactivity will enable their optimization as antimicrobial
agents and will guide the development of these materials in
nanomedicine and for environmental applications. For
instance, the antibacterial effects of AgNPs may be strongly
improved by using AgNPs coated with specific groups that
enable their binding to cations or sulphur containing pro-
teins present on the bacterial membrane, or by increasing
the electrostatic interaction with the negatively charged cell
wall. Moreover, treatment of bacterial infections is difficult
due to the lack of known cellular targets of infected cells.
Further research to identify these targets could lead to the
design of novel antibacterial agents based on AgNPs coated
with ligands that target specific receptors.
One of the reasons which make AgNPs attractive as anti-
bacterial agents is the fact that bacteria are not likely to
become resistant to silver like antibiotics, due to the wide
range of possible interactions of Ag+ ions with biomolecules.
The biggest challenge will be to determine the “therapeuticThis journal is © The Royal Society of Chemistry 2015
Environmental Science: Nano Critical review
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
9 
Ju
ne
 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
5/
02
/2
01
6 
11
:2
8:
15
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Onlinewindow” where AgNPs can be used as antibacterial therapeu-
tics for infected cells without affecting the metabolism of
healthy cells.57 AgNPs have been identified as a possible
exposure hazard91 and they have been shown to cause inflam-
mation in the lung following inhalation. In inhalation studies
using rodents, AgNPs induce pulmonary inflammation with
mixed cellular infiltrates and decreased minute volumes,
leading to the development of pulmonary function
abnormalities.92–94 Recently, Wang et al. compared the
effects of 20 and 110 nm AgNPs and demonstrated more
acute pulmonary effects of the smaller particles, whereas the
110 nm particles induced mild pulmonary fibrosis.95 The
authors suggested that these differences arose due to a differ-
ence in the rate at which Ag+ ions were released from the par-
ticles. Consequently, controlling the reactivity of AgNPs will
depend on controlling the size and surface chemistry of
AgNPs.
Undeniably, AgNPs hold a great potential for the develop-
ment of novel treatment options for bacterial infections.
There are certainly still several challenges to overcome in the
design of AgNPs for medical applications, but a high control
over their properties, an improved fundamental understand-
ing of their bioreactivity pathways and the application of
advanced and accurate nanometrology may hold the key that
will open the door for the development of safe AgNP plat-
forms for therapeutic treatment and bio-imaging
applications.
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